2026-06-27T13:55:34Zhttps://docta.ucm.es/rest/oai/request

oai:docta.ucm.es:20.500.14352/1006482025-03-18T12:48:33Zcom_20.500.14352_14col_20.500.14352_15

Miguel Díez, Javier De Albaladejo Vicente, Romana Hernández Barrera, Valentín Ji, Zichen López Herranz, Marta Jiménez García, Rodrigo López De Andrés, Ana Isabel 2024-02-09T07:23:04Z 2024-02-09T07:23:04Z 2020-06-25 de Miguel-Diez J, Albaladejo-Vicente R, Hernández-Barrera V, Ji Z, Lopez-Herranz M, Jimenez-Garcia R, López-de-Andrés A. Hospital admissions for community-acquired, ventilator-associated and nonventilator hospital-acquired pneumonia in COPD patients in Spain (2016-2017). Eur J Intern Med. 2020 Sep;79:93-100. doi: 10.1016/j.ejim.2020.06.028. Epub 2020 Jun 30. PMID: 32616338. 0953-6205 10.1016/j.ejim.2020.06.028 https://hdl.handle.net/20.500.14352/100648 https://www.sciencedirect.com/science/article/pii/S0953620520302740?via%3Dihub https://pubmed.ncbi.nlm.nih.gov/32616338/ Background: To examine the incidence, characteristics and outcomes of community-acquired pneumonia (CAP), ventilator-associated pneumonia (VAP) and nonventilator hospital-acquired pneumonia (NV-HAP) in patients with or without COPD; compare in-hospital outcomes; and identify factors associated with in-hospital mortality (IHM) for pneumonia. Methods: We carried out a retrospective observational study using the hospital discharge records from 2016-17 of the Spanish National Health System. Propensity score matching was used for data analysis. Results: We found 245,905 patients (≥40 years) with pneumonia; we identified CAP in 228,139 patients (19.85% with COPD), VAP in 2,771 patients (8.55% with COPD) and NV-HAP in 14,995 patients (14.17% with COPD). The incidence for the three types of pneumonia was higher in COPD patients (CAP: incidence rate ratio (IRR) 2.23, 95% CI 2.21-2.26; VAP: IRR 1.25, 95% CI 1.08-1.42; and NV-HAP: IRR 1.55, 95% CI 1.48-1.63). The IHM for CAP was 10.35% in COPD patients and 12.91% in the controls (p<0.001). In patients with VAP and NV HAP, IHM was not significantly different between those with and without COPD (43.88% vs. 41.77%;p=0.643 and 29.21% vs. 30.57%;p=0.331, respectively). Factors associated with IHM for all types of pneumonia ana lyzed in COPD patients were older age and receiving dialysis. Conclusions: The incidence of hospitalizations for all types of pneumonia was significantly higher in COPD patients than in the non-COPD population. In contrast, IHM was significantly lower among COPD patients with CAP than among matched non-COPD patients. Higher mortality rates in COPD patients with any pneumonia type were associated with increasing age and receiving dialysis. eng restricted access Hospital admissions for community-acquired, ventilator-associated and nonventilator hospital-acquired pneumonia in COPD patients in Spain (2016-2017) journal article